<VariationArchive VariationID="458347" VariationName="NM_001114753.3(ENG):c.392del (p.Pro131fs)" VariationType="Deletion" Accession="VCV000458347" Version="11" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-07-29" DateCreated="2018-10-10" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="458792" VariationID="458347">
      <GeneList>
        <Gene Symbol="ENG" FullName="endoglin" GeneID="2022" HGNC_ID="HGNC:3349" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>9q34.11</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="127815016" stop="127854658" display_start="127815016" display_stop="127854658" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="130577290" stop="130617046" display_start="130577290" display_stop="130617046" Strand="-" />
          </Location>
          <OMIM>131195</OMIM>
          <Haploinsufficiency last_evaluated="2024-01-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ENG">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2024-01-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ENG">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_001114753.3(ENG):c.392del (p.Pro131fs)</Name>
      <CanonicalSPDI>NC_000009.12:127826640:GGGGG:GGGG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>9q34.11</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="127826641" stop="127826641" display_start="127826641" display_stop="127826641" variantLength="1" positionVCF="127826640" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="130588920" stop="130588920" display_start="130588920" display_stop="130588920" variantLength="1" positionVCF="130588919" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>P131fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_589" sequenceAccession="LRG_589">
            <Expression>LRG_589:g.33128del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000118.3" sequenceAccession="NM_000118" sequenceVersion="3" change="c.392delC">
            <Expression>NM_000118.3:c.392delC</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.130588924del" Assembly="GRCh37">
            <Expression>NC_000009.11:g.130588924del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.127826645del" Assembly="GRCh38">
            <Expression>NC_000009.12:g.127826645del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009551.1" sequenceAccession="NG_009551" sequenceVersion="1" change="g.33128del">
            <Expression>NG_009551.1:g.33128del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000118.4" sequenceAccession="NM_000118" sequenceVersion="4" change="c.388delC">
            <Expression>NM_000118.4:c.388delC</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000109.1" sequenceAccession="NP_000109" sequenceVersion="1" change="p.Pro131Argfs">
            <Expression>NP_000109.1:p.Pro131Argfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001114753.2" sequenceAccession="NM_001114753" sequenceVersion="2" change="c.388delC">
            <Expression>NM_001114753.2:c.388delC</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001108225.1" sequenceAccession="NP_001108225" sequenceVersion="1" change="p.Pro131Argfs">
            <Expression>NP_001108225.1:p.Pro131Argfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001114753.3" sequenceAccession="NM_001114753" sequenceVersion="3" change="c.392del" MANESelect="true">
            <Expression>NM_001114753.3:c.392del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001108225.1" sequenceAccession="NP_001108225" sequenceVersion="1" change="p.Pro131fs">
            <Expression>NP_001108225.1:p.Pro131fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001278138.2" sequenceAccession="NM_001278138" sequenceVersion="2" change="c.-155del">
            <Expression>NM_001278138.2:c.-155del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001406715.1" sequenceAccession="NM_001406715" sequenceVersion="1" change="c.388delC">
            <Expression>NM_001406715.1:c.388delC</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001393644.1" sequenceAccession="NP_001393644" sequenceVersion="1" change="p.Pro131Argfs">
            <Expression>NP_001393644.1:p.Pro131Argfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_589t1" sequenceAccession="LRG_589t1">
            <Expression>LRG_589t1:c.392del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_589p1" sequenceAccession="LRG_589p1" change="p.Pro131fs">
            <Expression>LRG_589p1:p.Pro131fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_589t2" sequenceAccession="LRG_589t2">
            <Expression>LRG_589t2:c.392del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_589p2" sequenceAccession="LRG_589p2" change="p.Pro131fs">
            <Expression>LRG_589p2:p.Pro131fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA658656043" DB="ClinGen" />
        <XRef Type="rs" ID="1554810510" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001114753.3(ENG):c.392del (p.Pro131fs) AND Spontaneous, recurrent epistaxis" Accession="RCV001281495" Version="10">
        <ClassifiedConditionList TraitSetID="65054">
          <ClassifiedCondition DB="MedGen" ID="C3809715">Spontaneous, recurrent epistaxis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-09-13" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001114753.3(ENG):c.392del (p.Pro131fs) AND Hereditary hemorrhagic telangiectasia" Accession="RCV002231267" Version="14">
        <ClassifiedConditionList TraitSetID="43931">
          <ClassifiedCondition DB="MedGen" ID="C0039445">Hereditary hemorrhagic telangiectasia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-11-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001114753.3(ENG):c.392del (p.Pro131fs) AND Telangiectasia, hereditary hemorrhagic, type 1" Accession="RCV003319369" Version="9">
        <ClassifiedConditionList TraitSetID="7437">
          <ClassifiedCondition DB="MedGen" ID="C4551861">Telangiectasia, hereditary hemorrhagic, type 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-11-08" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2018-10-10" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15879500</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16542389</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30251589</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="65054" Type="Finding" ContributesToAggregateClassification="true">
            <Trait ID="24435" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Spontaneous, recurrent epistaxis</ElementValue>
                <XRef ID="HP:0004406" DB="Human Phenotype Ontology" />
              </Name>
              <XRef ID="C3809715" DB="MedGen" />
              <XRef Type="primary" ID="HP:0004406" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0003684" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="43931" Type="Finding" ContributesToAggregateClassification="true">
            <Trait ID="40362" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Osler Weber Rendu syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ORW disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osler-Rendu-Weber disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osler hemorrhagic telangiectasia syndrome</ElementValue>
                <XRef ID="Osler+hemorrhagic+telangiectasia+syndrome/9046" DB="Genetic Alliance" />
                <XRef ID="21877004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary hemorrhagic telangiectasia</ElementValue>
                <XRef ID="MONDO:0019180" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HHT</ElementValue>
                <XRef ID="GTR000525320" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="187300" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000515719" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500010" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6626" />
                <XRef ID="6626" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="774" DB="Orphanet" />
              <XRef ID="C0039445" DB="MedGen" />
              <XRef ID="MONDO:0019180" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS187300" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="7437" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="16695" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Telangiectasia, hereditary hemorrhagic, type 1</ElementValue>
                <XRef ID="MONDO:0008535" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osler Weber Rendu syndrome type 1</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HHT1</ElementValue>
                <XRef Type="MIM" ID="187300" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ORW1</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000506221" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000553700" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000227625" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000505110" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512361" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000511259" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000562015" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000506222" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558916" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528884" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000515716" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000509787" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000509788" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528531" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000515719" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500545" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500544" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000506220" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Hereditary hemorrhagic telangiectasia (HHT) is characterized by the presence of multiple arteriovenous malformations (AVMs) that lack intervening capillaries and result in direct connections between arteries and veins. The most common clinical manifestation is spontaneous and recurrent nosebleeds (epistaxis) beginning on average at age 12 years. Telangiectases (small AVMs) are characteristically found on the lips, tongue, buccal and gastrointestinal (GI) mucosa, face, and fingers. The appearance of telangiectases is generally later than epistaxis but may be during childhood. Large AVMs occur most often in the lungs, liver, or brain; complications from bleeding or shunting may be sudden and catastrophic. A minority of individuals with HHT have GI bleeding, which is rarely seen before age 50 years.</Attribute>
                <XRef ID="NBK1351" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary Hemorrhagic Telangiectasia</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301525</ID>
                <ID Source="BookShelf">NBK1351</ID>
              </Citation>
              <Citation Type="general" Abbrev="HHT Foundation Int'l, 2011">
                <ID Source="PubMed">19553198</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Shovlin et al., 2000">
                <ID Source="PubMed">10751092</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="general" Abbrev="HHT Foundation Int'l, 2020">
                <ID Source="PubMed">32894695</ID>
              </Citation>
              <XRef ID="774" DB="Orphanet" />
              <XRef ID="C4551861" DB="MedGen" />
              <XRef ID="MONDO:0008535" DB="MONDO" />
              <XRef Type="MIM" ID="187300" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2894519" SubmissionDate="2020-12-04" DateLastUpdated="2021-01-17" DateCreated="2021-01-17">
        <ClinVarSubmissionID localKey="NM_001114753.2:c.392del" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001468804" DateUpdated="2021-01-17" DateCreated="2021-01-17" Type="SCV" Version="1" SubmitterName="New York Genome Center" OrgID="507558" OrganizationCategory="laboratory" OrgAbbreviation="NYGC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-09-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16542389</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30251589</ID>
          </Citation>
          <Comment>The c.392del (p.Pro131ArgfsTer32) variant identified in the ENG gene is the deletion of a single nucleotide resulting in the frameshift of the protein at amino acid 131/659 (coding exon 4/15), which is predicted to lead to the premature termination of the protein approximately 32 amino acids downstream of the variant. This variant is absent from gnomAD and ExAC, suggesting it is not a common benign variant in the populations represented in these databases. This variant is classified as Pathogenic in ClinVar (VarID:458347), and has been identified in two individuals in the literature with hereditary haemorrhagic telangiectasia [PMID: 16542389; PMID: 30251589]. This variant was identified in a proband submitted for clinical testing, and found to be inherited from an affected parent. The c.392del (p.Pro131ArgfsTer32) variant is reported here as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">NYGC Assertion Criteria 2020</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/hhfhf6ms/nygc_assertion_criteria_2020.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>paternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <FamilyData SegregationObserved="yes">
                <FamilyHistory>yes</FamilyHistory>
              </FamilyData>
            </Sample>
            <Method>
              <NamePlatform>HiSeq X</NamePlatform>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">whole genome sequencing</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="NumberMosaic" integerValue="0" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SecondaryFinding">no</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Seizures</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001250" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Dandy-Walker syndrome</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001305" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Cerebral palsy</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0100021" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001114753.2:c.392del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="HP" ID="HP:0004406" />
          </Trait>
        </TraitSet>
        <StudyName>CSER-NYCKidSeq</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB8686090</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7528583" SubmissionDate="2023-08-09" DateLastUpdated="2023-08-13" DateCreated="2023-08-13">
        <ClinVarSubmissionID localKey="9-130588924-GC-C|OMIM:187300" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004024115" DateUpdated="2023-08-13" DateCreated="2023-08-13" Type="SCV" Version="1" SubmitterName="Genomics And Bioinformatics Analysis Resource, Columbia University" OrgID="509221" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ENG" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001114753.3:c.392del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="187300" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment>Heterozygous</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB13748295</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1221788" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2017-12-26">
        <ClinVarSubmissionID localKey="1555295|MedGen:C0039445" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000629570" DateUpdated="2024-02-20" DateCreated="2017-12-26" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-11-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16542389</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15879500</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 458347). This premature translational stop signal has been observed in individuals with epistaxis, telangiectasias and gastrointestinal bleeding (PMID: 16542389). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Pro131Argfs*32) in the ENG gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ENG are known to be pathogenic (PMID: 15879500).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ENG" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.11:g.130588920del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0039445" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
          <SubmissionName>SUB4474525</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2894519" TraitType="Finding" MappingType="Name" MappingValue="Seizures" MappingRef="Preferred">
        <MedGen CUI="C0036572" Name="Seizure" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1221788" TraitType="Disease" MappingType="XRef" MappingValue="C0039445" MappingRef="MedGen">
        <MedGen CUI="C0039445" Name="Hereditary hemorrhagic telangiectasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2894519" TraitType="Finding" MappingType="Name" MappingValue="Cerebral palsy" MappingRef="Preferred">
        <MedGen CUI="C0007789" Name="Cerebral palsy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2894519" TraitType="Finding" MappingType="XRef" MappingValue="HP:0004406" MappingRef="HP">
        <MedGen CUI="C3809715" Name="Spontaneous, recurrent epistaxis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2894519" TraitType="Finding" MappingType="Name" MappingValue="Dandy-Walker syndrome" MappingRef="Preferred">
        <MedGen CUI="C0010964" Name="Dandy-Walker syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7528583" TraitType="Disease" MappingType="XRef" MappingValue="187300" MappingRef="OMIM">
        <MedGen CUI="C4551861" Name="Telangiectasia, hereditary hemorrhagic, type 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

